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Abstract
Objectives: Prescription errors occur frequently in pediatric emergency departments (PEDs).The effect of
computerized physician order entry (CPOE) with electronic medication alert system (EMAS) on these is
unknown. The objective was to compare prescription errors rates before and after introduction of CPOE
with EMAS in a PED. The hypothesis was that CPOE with EMAS would significantly reduce the rate and
severity of prescription errors in the PED.
Methods: A prospective comparison of a sample of outpatient, medication prescriptions 5 months before
and after CPOE with EMAS implementation (7,268 before and 7,292 after) was performed. Error types
and rates, alert types and significance, and physician response were noted. Medication errors were
deemed significant if there was a potential to cause life-threatening injury, failure of therapy, or an
adverse drug effect.
Results: There was a significant reduction in the errors per 100 prescriptions (10.4 before vs. 7.3 after;
absolute risk reduction = 3.1, 95% confidence interval [CI] = 2.2 to 4.0). Drug dosing error rates
decreased from 8 to 5.4 per 100 (absolute risk reduction = 2.6, 95% CI = 1.8 to 3.4). Alerts were
generated for 29.6% of prescriptions, with 45% involving drug dose range checking. The sensitivity of
CPOE with EMAS in identifying errors in prescriptions was 45.1% (95% CI = 40.8% to 49.6%), and the
specificity was 57% (95% CI = 55.6% to 58.5%). Prescribers modified 20% of the dosing alerts, resulting
in the error not reaching the patient. Conversely, 11% of true dosing alerts for medication errors were
overridden by the prescribers: 88 (11.3%) resulted in medication errors, and 684 (88.6%) were false-
positive alerts.
Conclusions: A CPOE with EMAS was associated with a decrease in overall prescription errors in our
PED. Further system refinements are required to reduce the high false-positive alert rates.
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Medication errors occur more frequently inchildren than in adults.1 Some of the postu-lated reasons for these increased rates of
medication errors in children are the need to calculate
doses based on weight and the need to reformulate
many medications, which are packaged primarily for
adults.2 Pediatric emergency departments (PEDs) are a
particularly vulnerable area for medications errors,3
with a 10% to 12% prescribing error rate.4,5
In an effort to reduce medication errors in children,
many institutions have implemented computerized phy-
sician order entry (CPOE).6,7 Implementation of CPOE
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can decrease medication errors significantly. In a meta-
analysis of 25 studies that evaluated the effects of CPOE
on the medication error rate, 23 showed statistically sig-
nificant relative risk reductions of 13% to 99%.8 How-
ever, Bobb et al.9 found that 13.2% of these errors
could not be prevented by CPOE alone. More impor-
tantly, prescribing errors with the potential for patient
harm were less likely to be prevented.9
Therefore, refinement of CPOE with clinical decision
support systems is being promoted as a tool to reduce
prescription errors. Clinical decision support can pro-
vide either basic (e.g., drug allergy checking) or
advanced (e.g., drug dosing support for renal insuffi-
ciency) guidance for the prescriber. In a systematic
review of 10 studies evaluating CPOE with clinical deci-
sion support systems, five were associated with statisti-
cally significant decreases in adverse drug events.10
However, these studies were performed in either inpa-
tient hospital settings or outpatient clinics. The effect of
such refined CPOE systems in the PED, particularly on
the outpatient prescription medication errors, is not
known. Our institution introduced decision support
(electronic medication alert system [EMAS]) to our
existing CPOE for outpatient prescriptions in 2010. The
software alerts the clinician to errors in dosing, fre-
quency, drug allergy, and drug-to-drug interactions and
provides the prescriber with the opportunity to modify
the prescription. The objective of this study was to test
the hypotheses that addition of the EMAS to existing
CPOE reduces the rate and severity of outpatient pre-
scription errors in the PED.
METHODS
Study Design
This was a prospective before-and-after study of outpa-
tient medication prescriptions provided to children
younger than 18 years, who were discharged from our
PED. This study was approved by our institutional
review board.
Study Setting and Population
The study was performed at an inner-city PED with
approximately 92,000 visits per year, in a free-standing
children’s hospital that is a Level I trauma center. Of the
total visits to our PED, 88% of patients are discharged
home; nearly 50% of these are provided medication pre-
scriptions.
The preimplementation period included the 5-month
period of January 2010 through May 2010. The decision
support was implemented in October 2010. The postim-
plementation period included the 5-month period of
January 2011 through May 2011. A randomly selected
sample of prescriptions from the preimplementation
period was compared with a similarly selected sample
postimplementation. Prescriptions were excluded if they
were for equipment or medical supplies, such as nebu-
lizers. Medication orders that were written on admitted
patients or as part of ongoing patient care prior to dis-
charge from the PED were not reviewed.
Electronic Medication Alert System. Our PED imple-
mented CPOE in December 2006, using Cerner (Cerner
Corporation Inc., Kansas City, MO; version 2007.19.12),
which was then upgraded in August 2010 with the addi-
tion of EMAS. This was introduced to alert the pre-
scriber to the presence of drug allergies, dose range
checking, harmful drug-to-drug interactions, and drug
frequency errors in outpatient prescriptions.
Study Protocol
For the duration of the study, an automated report of
all children who were discharged home from the PED
with medication prescriptions was provided by the
information technology support personnel. There were
19,358 patient visits during the pre-EMAS period and
17,362 patients visits during the post-EMAS period. A
simple random sample of 5,000 patient visits (including
multiple prescriptions per patient) pre-EMAS (from a
total of 19,358 patients) and post-EMAS (from a total of
17,632 patients) was generated using Minitab 17 for
analysis during each study period. The total number of
patient visits during the period and the sample size
required was entered into Minitab, which then gener-
ated a list of 5,000 random numbers. No limitations
were entered into the system; hence, each patient had
the same chance of being selected. Patient visits were
entered into an Excel sheet in order of the date and
time of presentation. The number generated by Minitab
was then matched to the corresponding patient in the
Excel spreadsheet. This study sample of patient visits
was cross-checked against the whole, and the similarity
in proportions of distributions between the two in type
of prescription, month and time of prescription, and
provider type was confirmed.
Two study research assistants abstracted the follow-
ing information from the medical record into an Excel
spreadsheet: patient’s age, demographics, weight,
known drug allergies, diagnosis for which the drug was
prescribed, time and date of prescription, prescriber
type (attending, resident, fellow, or nurse practitioner),
medication type, and details of the prescription such as
dose, frequency, and duration of therapy. During the
post-EMAS period, additional information included
alert generation, the type of alert to the drug prescribed
(drug–drug interaction, dose range checking, frequency,
drug–food allergy, drug duplicate orders, and drug
allergy) and physician response to the alert (override or
modify). The EMAS tracked physician responses to only
the dose range checking alerts, and hence only these
were available for analysis.
The spreadsheet was then made available to a single
study pharmacist (KPM), who was working full time on
this study. The study pharmacist also had access to the
entire electronic medical record, including information
regarding weight of the child, presence of medication
allergies, diagnosis, and the electronic prescription pro-
vided to the patient. This pharmacist, who was not
blinded to the date of the prescription, then analyzed all
prescriptions over a period of 2 months each (pre- and
post-EMAS) for the presence of dosing errors (defined
as >10% deviation of the weight- or age-appropriate
dose as recommended in pediatric Lexi-Comp), drug
allergy errors, drug–drug interactions, and dose fre-
quency errors.
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Errors were then classified as serious if they met one
of the following criteria: 1) potential to cause life-threat-
ening injury, 2) potential to cause failure of therapy, or
3) potential to cause non–life-threatening adverse drug
effects (e.g., diarrhea with antibiotics).
Based on those definitions, the study pharmacist also
classified alerts as serious or nonserious. The study
principal investigator (US) then randomly reviewed 20%
of the prescriptions (2,912 prescriptions) to verify accu-
racy of the pharmacist’s classification of errors. In cases
of discrepancy of error and alert classification between
the pharmacist and the principal investigator (PI), the
decision of the PI was considered as final.
Data Analysis
All data were entered into an Excel spreadsheet (ver-
sion 2002) by a single research assistant and variables
were systematically coded for analysis. Inter-rater reli-
ability was measured using kappa statistic. Descriptive
statistics were used to describe the study sample,
medication error rates, and error types. Poisson rate
ratio was used to compare the differences in the
medication error rates between prescriptions in the
pre- and post-EMAS groups, with no serious overdi-
spersion detected in the data. Error rates are
expressed as errors per 100 prescriptions. All statisti-
cal tests were two-tailed and performed at the 5%
level of significance. The confidence intervals (CI) for
the percentages were calculated as 95% CI. For
patients with more than one prescription, we also
measured the proportion of errors that occurred with
the last prescription. We used an interrupted time-ser-
ies analysis, with segmented linear regression, to esti-
mate the change in error rate and the change in the
slope of error rates after the intervention. We used
the autoregressive time series analysis with Cochrane-
Orcutt method to correct for the autocorrelation effect
in the time series.
All data were analyzed using SPSS version 21. We
had performed a preliminary review of error rate in
outpatient prescriptions in our ED as part of a quality
improvement initiative. This provided us the baseline
error rate of 15%. A previous study from a pediatric
intensive care unit showed a reduction in potential med-
ication adverse events from 2.4% to 0.7% between two
periods which used CPOE and CPOE with clinical deci-
sion support system, respectively. Sample size calcula-
tion using a baseline error rate of 15% and a reduction
of 2% to achieve a power of 80% required a sample size
of 4,724 patient visits per study period.
RESULTS
We analyzed 10,000 patient visits, with 14,560 prescrip-
tions (7,268 pre- and 7,292 post-EMAS). The kappa for
agreement between the pharmacist and the PI regard-
ing classification of error and alerts was 0.75 (95%
CI = 0.49 to 1).
Patient demographics and prescription characteristics
are shown in Table 1. Overall, during the study period,
there were 8.88 errors per 100 prescriptions. The most
common medication errors involved antibiotics. The
most common type of error was a dosing error, which
was significantly reduced in the post-EMAS period
(Table 2).
There was a statistically significant reduction in the
overall error rate between the pre- and post-EMAS
periods (10.4 per 100 prescriptions preimplementation
vs. 7.3 postimplementation, absolute risk reduction =
3.1%, 95% CI = 2.2% to 4%). This was primarily due to
a decrease in drug dose errors, which decreased from 8
per 100 to 5.4 (absolute risk reduction = 2.6 per 100,
95% CI = 1.7 to 3.3). There was no decrease in the rate
of prescriptions with serious errors (pre-EMAS, 4.9 per
100; post-EMAS, 4.5 per 100; absolute risk reduction =
0.4 per 100, 95% CI = –0.3 to 1.0). A time-series analysis
of the above effect of EMAS on medication error reduc-
tion is shown in Figure 1. There was a statistically sig-
nificant change in both the overall error rate (p < 0.01)
and the slope of the rate of change of error rate
(p = 0.006) comparing the pre- and post-EMAS periods.
Among patients with multiple prescriptions, the major-
ity of the medication errors occurred in the last
prescription, and this was significantly reduced in the
Table 1
Patient Demographics and Prescription Characteristics Before
and After EMAS Implementation
Variable Pre-EMAS Post-EMAS p-value
Sex
Male 2,638 (52.8) 2,682 (53.6) 0.378
Female 2,362 (47.2) 2,318 (46.4)
Age group (yr)
<1 647 (12.9) 727 (14.5) 0.214
1–5 2,301 (46) 2,264 (45.3)
6–10 1,068 (21.4) 1,034 (20.7)
11–15 728 (14.6) 731 (14.6)
>16 256 (5.1) 244 (4.9)
Number of medications prescribed
1 3,238 (64.8) 3,206 (64.1) 0.566
2 1,284 (25.7) 1,287 (25.7)
≥3 476 (9.5) 507 (10.1)
Time of day (hr)
7:01–15:00 1,509 (30.2) 1,496 (29.9) 0.663
15:01–23:00 2,277 (45.5) 2,251 (45.0)
23:01–7:00 1,214 (24.3) 1,253 (25.1)
Prescriber type
PEM attending 1,539 (30.8) 1,525 (30.5) 0.000
Pediatrics attending 673 (13.5) 551 (11)
PEM fellow 303 (6.1) 303 (6.1)
Resident 2,087 (41.7) 2,140 (42.8)
Nurse practitioner 398 (8) 514 (10.3)
Data are reported as n (%).
EMAS = electronic medication alert system; PEM = pediatric
emergency medicine.
Table 2
Type of Errors Before and After EMAS Implementation
Type of Error Pre-EMAS Post-EMAS p-value
Dosing 582 (8) 398 (5.4) <0.0001
Frequency 110 (1.5) 96 (1.3) 0.3243
Drug-to-drug interaction 8 (0.1) 7 (0.1) 0.7961
Allergy 17 (0.2) 6 (0.1) 0.0217
Data are reported as n (%).
EMAS = electronic medication alert system.
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post-EMAS period (pre-EMAS 611 of 735 [80.9%] vs.
post-EMAS 395 of 531 [74.2%]; p < 0.05).
Alerts were generated for 2,161 (29.6%) prescriptions
in the post-EMAS period, of which 6% were serious.
Overall, the sensitivity of EMAS alerts in identifying
errors in prescriptions was 45.1% (95% CI = 40.8% to
49.6%) and the specificity was 57% (95% CI = 55.6% to
58.5%). Of the total alerts, 959 (44.4%) involved drug
dose range checking, 317 (14.3%) drug–drug interac-
tions, 510 (23.6%) drug duplicate, eight (3.7%) drug
allergy, 236 (10.9%) drug-to-food allergy, and 128 (5.9%)
involved multiple alerts.
Among the 959 prescriptions that had dose range
checking alerts generated, 187 (19.5%) were modified
by the physician, thus preventing the error from reach-
ing the patient. Alerts were ignored or overridden by
the physician for 772 prescriptions, of which 88 (11.3%)
resulted in medication errors, and 684 (88.6%) were
false-positive alerts.
DISCUSSION
Computerized physician order entry with clinical deci-
sion support was associated with a reduction in reduc-
ing outpatient medication prescription errors by 29% in
our PED, but not with the reduction of serious errors.
The observed reduction in errors was predominantly
related to a decrease in antibiotics errors and dosing
errors. This reduction came at a cost to users of approx-
imately 43% false-positive alerts and overriding of
important dose range checking alerts in 11% of pre-
scriptions. This suggests that the decision support
needs refinement to improve its specificity.
To our knowledge, this is the first study of its kind
conducted in a pediatric ED. The ED has the highest
rate of medication errors (6%) and preventable
adverse drug events in hospitals.3,11,12 Despite the high
rates of errors among prescribed medications, there
are scant data in literature regarding the efficacy of
CPOE with or without clinical decision support sys-
tems in pediatrics and particularly in the PED. Further,
those studies that do exist in the pediatric literature
have been conflicting in whether CPOE with clinical
decision support systems reduces medication errors.
Kadmon et al.13 investigated the change in prescription
error rates with the introduction of CPOE with and
without a clinical decision support system limited to
weight-based dosing in a pediatric intensive care unit.
They showed that while the introduction of CPOE
reduced the potential adverse events and medication
errors only slightly, the addition of a clinical decision
support system reduced these errors significantly.13
Walsh et al.14 also reported a minor reduction in pre-
scription errors in a pediatric hospital using a CPOE
with dosing checking alerts. In contrast, Mullett et al.15
found no difference in their study of adverse drug
events due to anti-infective therapy with implementa-
tion of CPOE with clinical decision support system in
an pediatric intensive care unit.
In the only other study from the pediatric ED, Sard
et al.16 reported a 55% reduction in medication pre-
scribing errors after implementation of a local clinical
decision support system called “quick list.” We observed
a similar, albeit smaller, drop (29%) in the error rates
after implementation of EMAS. Possible explanations
for the observed difference in decreased error rates
between the two studies are that our study only
included medication prescriptions at discharge and
studied only four specific medication errors. We did not
include duplicate orders, details such as missing weight,
and hospital policy violations that were included by
Sard et al.16
One finding in our study was that errors were more
likely to occur when there were multiple prescriptions
for a single patient and were more likely to occur with
the last prescription. While our study design did not
allow us to determine the reasons for this, it is possible
that prescriber fatigue occurs with successive prescrip-
tion writing. Alternatively, providers may feel rushed to
complete multiple prescriptions to maintain patient
throughput. Whatever the reason, this error in the last
prescription was significantly reduced in the post-EMAS
period, suggesting that clinical decision support systems
can directly affect this area of error.
Figure 1. Time-series analysis showing prescription errors before and after electronic medication alert system implementation.
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We observed no difference in serious error rates pre-
and post-EMAS. This is likely related to the rarity of
serious errors. A study demonstrating a reduction of
serious errors from 4.9% to 4.5%, the rates in our
study, would require approximately 44,000 patients in
each group to achieve 80% power.
It is important to note that only 19.5% of alerts were
accepted by physicians, resulting in modifications of
flawed prescriptions. Perhaps equally important is the
fact that 11% of alerts for true errors were overridden
by the prescriber. Reports of overriding the alert by the
prescriber range from 49% to 96% in literature.17 Rea-
sons cited for alert override include alert fatigue, physi-
cians’ faith in their own knowledge, and difficulty in
interpretation of the alerts and the clinical conse-
quences. In this study, the high rate of false-positive
alerts generated could have contributed to alert fatigue,
leading to clinicians overriding important alerts. One of
the reasons for the high rate of false-positive alerts is
that our clinical decision support system was not
designed to consider the specific indication for which
the drug was ordered (e.g., normal versus high-dose
amoxicillin for otitis media) or the patient’s underlying
clinical status (e.g., renal function). In addition, one-fifth
of the alerts that were generated were for duplicate pre-
scriptions. Our study results thus suggest that while
CPOE with clinical decision support was associated
with decreased error rates among outpatient prescrip-
tions in the PED, further refinements are needed to
decrease the false-positive alert rates.
LIMITATIONS
We evaluated only a random sample of outpatient pre-
scriptions during the study period. It is possible that the
overall error rate and the reduction would have been
different if we had studied all prescriptions written dur-
ing the study period. However, the prescriptions that
were analyzed were randomly selected, thus decreasing
the likelihood of bias. We also did not account for
potential unmeasured confounding variables or secular
trends that might have contributed to the reduction in
errors in the post-EMAS period. However, EMAS was
the only change to the prescribing process that was
implemented during the study period.
A further limitation of the study is that we did not
evaluate the number of the prescription errors that
actually resulted in patient harm. We were able to eval-
uate physician responses only to dose range checking
alerts and not for the other type of alerts. Further, we
did not study the reasons behind the physician
responses to the alerts; as with our existing EMAS, phy-
sicians have an option of not providing this. None of
the study personnel who reviewed the prescriptions for
errors were blinded to the prescription date and hence
may have been inherently biased, which may have influ-
enced the error rate.
CONCLUSIONS
The addition of clinical decision support to an existing
computerized physician order entry was associated with
a reduction in the overall electronic, ambulatory pre-
scription errors in our pediatric emergency department.
There was, however, no reduction in the rate of serious
medication errors. This alert system was associated
with high false-positive rates. Further refinements are
required to improve specificity and reduce prescriber
alert fatigue.
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